| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3610 | |||||||||||||||||||||||
| Submitter : | Mr. Joseph O'Kane | Date & Time: | 12/19/2006 09:12:33 | |||||||||||||||||||||
| Organization : | Mr. Joseph O'Kane | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I would like to register my strong objection to the use of fetal cell lines in the development of any vaccines. I feel that as a taxpayer that indirectly provides funds to the FDA, I should have a voice in what the FDA determines as "acceptable practices". To a large portion of the US taxpayers, use of fetal (specifically, aborted) cell lines is unethical and immoral.
I respectfully request that the FDA reconsiders its guidelines for pharmaceutical companies. It is imperative that a recommendation that these companies do NOT use aborted fetal cell lines is included in these guidelines. If FDA does not reconsider these guidelines, then in my opinion this "Federal" agency that is supposed to represent the entire population of the US (specifically the taxpayers who are funding it) is not doing its ethical duty. I look forward to reading about the newly updated guidelines in 2007. | ||||||||||||||||||||||||